Goodrx Holdings, Inc. ( (GDRX) ) has released its Q4 earnings. Here is a breakdown of the information Goodrx Holdings, Inc. presented to its investors.
GoodRx Holdings, Inc., a prominent U.S. prescription savings platform, connects consumers with healthcare professionals and pharmacies to facilitate cost-effective access to medications. The company recently announced its financial results for the fourth quarter and full year of 2024, which aligned closely with previous guidance. Key highlights include a quarterly revenue of $198.6 million and an annual revenue of $792.3 million, reflecting a 6% increase from the previous year. The company achieved a net income of $16.4 million for the year, a significant improvement from a net loss in 2023, driven by top-line growth and cost-saving measures. GoodRx also reported a strong adjusted EBITDA of $260.2 million, marking a 20% increase year-over-year. The company ended the year with over 7 million consumers utilizing its prescription-related offerings. Looking ahead, GoodRx management is optimistic about continued growth, with revenue projections for 2025 ranging between $810 million and $840 million, and a focus on leveraging its core capabilities to enhance consumer access to affordable medications.